Back to User profile » Dr Erick Lansigan

Papers published by Dr Erick Lansigan:


The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy

Ujjani C, Mato A, Hill BT, Allan JN, Lansigan E, Jacobs R, Tuncer H, Pagel J, Brander D, Cheson B, Barr P, Roeker LE, Pu J, Shah NN, Goy A, Schuster SJ, Lamanna N, Sehgal A, Tam CS, Shadman M

Blood and Lymphatic Cancer: Targets and Therapy 2020, 10:1-5

Published Date: 24 August 2020

Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma

Frederick Lansigan, Diane M Stearns, Francine Foss

Cancer Management and Research 2010, 2:53-59

Published Date: 5 February 2010